CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017
3.2.2.2. Top Winning Strategies, By Development, 2014-2017 (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growth in geriatric female population
3.3.1.2. Increasing incidence of various chronic and lifestyle disorders in women
3.3.1.3. Rise in demand for point-of-care diagnostic testing
3.3.1.4. High adoption of imaging procedures

3.3.2. Restrains

3.3.2.1. High cost of imaging and monitoring systems
3.3.2.2. Lack of skilled professionals

3.3.3. Opportunities

3.3.3.1. Miniaturization of ultrasound devices
3.3.3.2. Untapped emerging economies

3.3.4. Impact analysis

CHAPTER 4 WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DIAGNOSTIC DEVICES

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Biopsy devices

4.2.3.1. Market size and forecast

4.2.4. Imaging and monitoring systems

4.2.4.1. Market size and forecast
4.2.4.2. Ultrasound imaging systems

4.2.4.2.1. Market size and forecast
4.2.4.2.2. OB/GYN ultrasound

4.2.4.2.2.1. Market size and forecast

4.2.4.2.3. Breast ultrasound

4.2.4.2.3.1. Market size and forecast

4.2.4.3. Mammography systems

4.2.4.3.1. Market size and forecast
4.2.4.3.2. Analog mammography systems

4.2.4.3.2.1. Market size and forecast

4.2.4.3.3. Digital mammography systems

4.2.4.3.3.1. Market size and forecast

4.2.4.3.4. Breast tomosynthesis

4.2.4.3.4.1. Market size and forecast

4.2.4.4. MRI systems

4.2.4.4.1. Market size and forecast

4.2.4.5. Nuclear imaging systems

4.2.4.5.1. Market size and forecast

4.3. DIAGNOSTIC TESTS

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Breast cancer testing

4.3.3.1. Market size and forecast
4.3.3.2. Hormone receptor test

4.3.3.2.1. Market size and forecast

4.3.3.3. Immunohistochemistry (IHC) test

4.3.3.3.1. Market size and forecast

4.3.3.4. Other breast cancer tests

4.3.3.4.1. Market size and forecast

4.3.4. Cervical cancer testing

4.3.4.1. Market size and forecast
4.3.4.2. PAP smear (PAP) test

4.3.4.2.1. Market size and forecast

4.3.4.3. HPV test

4.3.4.3.1. Market size and forecast

4.3.5. Prenatal genetic screening & carrier testing

4.3.5.1. Market size and forecast
4.3.5.2. Cystic fibrosis

4.3.5.2.1. Market size and forecast

4.3.5.3. Other diseases

4.3.5.3.1. Market size and forecast

4.3.6. Pregnancy & ovulation testing

4.3.6.1. Market size and forecast
4.3.6.2. Lab-based pregnancy & ovulation testing

4.3.6.2.1. Market size and forecast

4.3.6.3. Home-based pregnancy & ovulation testing

4.3.6.3.1. Market size and forecast

4.3.7. Ovarian cancer testing

4.3.7.1.1. Market size and forecast

4.4. ACCESSORIES & CONSUMABLES

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5 WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS AND CLINICS

5.2.1. Market size and forecast

5.3. HOME CARE SETTING

5.3.1. Market size and forecast

5.4. DIAGNOSTICS & IMAGING CENTERS

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

CHAPTER 6 WOMENS HEALTH DIAGNOSTICS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America womens health diagnostics market, by country

6.2.2.1. Market size and forecast

6.2.3. U.S.

6.2.3.1. U.S. womens health diagnostics market

6.2.4. Canada

6.2.4.1. Canada womens health diagnostics market

6.2.5. Mexico

6.2.5.1. Mexico womens health diagnostics market

6.2.6. North America womens health diagnostics market, by type
6.2.7. North America womens health diagnostics market, by end user

6.3. EUROPE

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe womens health diagnostics market, by country
6.3.3. Market size and forecast
6.3.4. Germany

6.3.4.1. Germany womens health diagnostics market

6.3.5. France

6.3.5.1. France womens health diagnostics market

6.3.6. UK

6.3.6.1. UK womens health diagnostics market

6.3.7. Italy

6.3.7.1. Italy womens health diagnostics market

6.3.8. Spain

6.3.8.1. Spain womens health diagnostics market

6.3.9. Rest of Europe

6.3.9.1. Rest of Europe womens health diagnostics market

6.3.10. Europe womens health diagnostics market, by type
6.3.11. Europe womens health diagnostics market, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific womens health diagnostics market, by country

6.4.2.1. Market size and forecast

6.4.3. China

6.4.3.1. China womens health diagnostics market

6.4.4. Japan

6.4.4.1. Japan womens health diagnostics market

6.4.5. India

6.4.5.1. India womens health diagnostics market

6.4.6. Australia

6.4.6.1. Australia womens health diagnostics market

6.4.7. South Korea

6.4.7.1. South Korea womens health diagnostics market

6.4.8. Rest of Asia-Pacific

6.4.8.1. Rest of Asia-Pacific womens health diagnostics market

6.4.9. Asia-Pacific womens health diagnostics market, by type
6.4.10. Asia-Pacific womens health diagnostics market, by end user

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA womens health diagnostics market, by country
6.5.3. Market size and forecast
6.5.4. Brazil

6.5.4.1. Brazil womens health diagnostics market

6.5.5. Saudi Arabia

6.5.5.1. Saudi Arabia womens health diagnostics market

6.5.6. South Africa

6.5.6.1. South Africa womens health diagnostics market

6.5.7. Rest of LAMEA

6.5.7.1. Rest of LAMEA womens health diagnostics market

6.5.8. LAMEA womens health diagnostics market, by type
6.5.9. LAMEA womens health diagnostics market, by end user

CHAPTER 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments

7.2. BECTON, DICKINSON AND COMPANY

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. CARDINAL HEALTH, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Product portfolio
7.3.4. Operating business segments
7.3.5. Business performance

7.4. CARESTREAM HEALTH INC.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio

7.5. COOK MEDICAL

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio

7.6. C. R. BARD INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. F. HOFFMANN-LA ROCHE LTD.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. HOLOGIC, INC.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

7.11. MEDGYN PRODUCTS, INC.

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Product portfolio

7.12. QUEST DIAGNOSTICS INCORPORATED.

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product portfolio
7.12.5. Business performance

7.13. SIEMENS AKTIENGESELLSCHAFT

7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Product portfolio
7.13.5. Business performance
7.13.6. Key strategic moves and developments

7.14. THERMO FISHER SCIENTIFIC, INC.

7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product portfolio
7.14.5. Business performance